Barroeta I, Videla L, Carmona-Iragui M et al (2025) Current advances and unmet needs in Alzheimers disease trials for individuals with Down syndrome: navigating new therapeutic frontiers
excluded participants demonstrates that the excluded group is generally comparable to the included group in terms of sociodemographic and health-related factors (Table S1)
Back Majzoub, JA, Kronenberg, HM, Potts, JT, et al (10 Aug 1979) 'Identification and cell-free translation of mRNA coding for a pre- cursor of parathyroid secretory protein', The Journal of Biological Chemistry , 254/15, 7449-55
10.1007/s00213-013-3290-7 18
In recent years, stronger versions of these GLP-1s were approved to help people with overweight and obesity